On November 2, 2021 Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported that Curis management will participate in virtual fireside chats and panels at the following upcoming conferences in November and December (Press release, Curis, NOV 2, 2021, View Source [SID1234594194]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

30th Annual Credit Suisse Healthcare Conference on Monday, November 8, 2021 at 1:00 p.m. ET
Jim Dentzer, President and CEO, will participate in the virtual fireside chat.
12th Annual Jefferies Global Healthcare Conference, starting on Thursday, November 18, 2021 at 3:00 a.m. ET (8:00 a.m. GMT).
Jim Dentzer, President and CEO, will participate in the virtual fireside chat that will be available for on-demand viewing during the conference.
B. Riley Fall Best Ideas in Oncology Panel Series on Wednesday, December 1, 2021 at 11:00 a.m. ET
Robert Martell, Head of Research and Development, will participate on the oncology panel series titled "Emerging Targeted Therapies in Acute Myeloid Leukemia"
Live webcasts of the Credit Suisse and B. Riley presentations will be available under "Events & Presentations" in the Investors section of the Company’s website at www.curis.com. Archived replays for all the events will be available on the Curis website for approximately 90 days following the event.